Intercept Pharmaceuticals delivered a bad news-good news punch over the weekend about its lead drug.
Durhane Wong-Rieger is the President & CEO of the Canadian Organization for Rare Disorders (CORD). In her first…
Brian Hilberdink, President of Novo Nordisk Canada, calls for the Canadian government to encourage and invest in…
After her son was diagnosed with SYNGAP1 – an extremely rare gene mutation – Monica Weldon founded Bridge the…